Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Tizaterkib | 2097416-76-5 | MFCD31631580 | 99.1% | 494.50 | 25 MG
Supplier: Medchemexpress LLC 25MGHY111483
Tizaterkib (AZD0364) is a potent and selective ERK2 inhibitor, with an IC50 of 0.6 nM. It is intended for research use only and not for patients.
- Potent and selective ERK2 inhibitor
- Inhibits the growth of cancer cell lines with KRAS mutations as monotherapy
- Enhances effect synergistically when combined with Selumetinib
- Reduces tumor growth in A549 xenograft models in combination with MEK inhibitor Selumetinib
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?